Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KeyCorp (KEY) vs Smith & Nephew plc (SNN) Price & Performance

KeyCorpTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

KeyCorp vs Smith & Nephew plc — how do they compare? KeyCorp trades at $23.22 (market cap $25.17B), while Smith & Nephew plc trades at $30.98 (market cap $12.64B). The key difference: KeyCorp is the larger of the two by market cap, and KeyCorp pays the higher dividend (3.52%). Which is the better fit depends on your goals.

KEYSNN
Market Cap
$25.17B$12.64B
Sector
FinancialsHealth
52-Week High
$23.99$38.70
52-Week Low
$16.78$28.73
Dividend Yield
3.52%2.57%
Enterprise Value
$15.41B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KeyCorp

KeyCorp (KEY) trades at $23.26, down 1.23% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results pending. Strong fundamentals include a 26.05% net income margin and 10.61% ROE, while valuation metrics show a P/E of 14.45 and P/B of 1.45. Recent corporate actions include consistent quarterly dividends of $0.21 per share and a new $3 billion buyback program announced in July 2026.

KEY presents a compelling investment case with analyst consensus pointing to significant upside (price target $30.50, 31% potential). The combination of earnings momentum, shareholder-friendly capital returns, and improving loan growth supports bullish sentiment. However, risks include potential pressure on net interest margins from Fed policy and competitive challenges in regional banking. The stock's current valuation appears reasonable relative to earnings growth prospects.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $30.43, down 0.54% on the day, with mixed technical signals showing a neutral overall stance. The company demonstrates improving fundamentals with 2024 revenue of $5.81 billion and net income of $412 million, representing a 7.09% margin. Recent product launches including the LYNX COBLATION Wand and CORI XT robotics platform highlight ongoing innovation. Cash flow trends show strong operational performance with $987 million from operations in 2024.

SNN presents a balanced investment case with improving profitability and product innovation offset by recent earnings misses. The stock trades at reasonable valuations (P/E 21.36, P/S 2.17) with analyst consensus leaning Hold (68%). Key risks include execution challenges and competitive pressures, while catalysts include robotics expansion and wound care leadership. The $500 million buyback program supports shareholder returns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About KeyCorp

With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.

Read more on KEY

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN